What makes us different
iMOST® (Instant Mobile Self-Test), first of the type, is based on outside-the-box thinking and a fundamentally different paradigm. The new paradigm is being realized through uniquely implementing nanotechnology, advance imaging, Nano-Enabled Artificial Intelligence/Machine-learning (NEAM) and new bio/chemical processes into diagnostic testing.
-
Nanotechnology
-
Advance Imaging
-
Nano-Enabled
Artificial intelligence -
New Bio/Chemistry
About us
At Essenlix, we are pioneering the future of health diagnostics with our groundbreaking iMOSTplatform. Our team, a dynamic and multidisciplinary group of experts from industry, healthcare, and academia, excels in bio-engineering, nanotechnology, advanced imaging, artificial intelligence, machine learning, and medicine. Essenlix was founded in 2013 by Dr. Stephen Chou and Dr. Lin Chou. Stephen Chou, is a professor at Princeton University, a member of the US National Academy of Engineering, a fellow of the US National Academy of Inventors, and a serial entrepreneur.